Difference between revisions of "About QIBA"
Jump to navigation
Jump to search
m (→QIBA’s® ROLE) |
m (→QIBA’s® ROLE) |
||
| Line 36: | Line 36: | ||
''Clinical Decisions from Quantitative Imaging'' | ''Clinical Decisions from Quantitative Imaging'' | ||
| − | ::[[Image:clinical decision.jpg| | + | ::[[Image:clinical decision.jpg|500px]] |
Revision as of 18:22, 19 November 2021
WHO IS QIBA®?
RSNA’s Quantitative Imaging Biomarkers Alliance (QIBA®) stakeholders include:
- clinical research community
- imaging equipment manufacturers
- pharmaceutical industry
- government agencies
- medical informatics companies
QIBA stakeholders ensure quantitative imaging results are:
- Consistent
- Achievable
- Reliable
- Validated
THE IMPORTANCE OF QUANTITATIVE IMAGING (QI)
QI develops, standardizes, and optimizes:
- Anatomical, functional, and molecular imaging acquisition protocols
- Data analyses
- Display methods
- Reporting structures
- Who is QIBA?
- Why is QI important?
QIBA’s® ROLE
- Efficient and validated methods for quantifying biomedical imaging results are required for optimal patient care, clinical research, and new therapy development.
- QIBA acceleratesBold text the development and adoption of hardware and software standards needed to achieve accurate and reproducible, quantitative (measurable) results from imaging methods.
Clinical Decisions from Quantitative Imaging
